positions available now

Category Archives: Life Sciences Industry

Relating to the Life Sciences Industry in general

Commercial Eyes at PharmAus19

The Commercial Eyes team had the pleasure of joining colleagues, clients, and representatives from across the pharmaceutical industry this week for PharmAus19 at Australia’s Parliament House. PharmAus is an annual event held in Canberra and hosted by Medicines Australia to … Continue reading

Posted in Commercial Eyes, Commercialisation Services, Life Sciences Industry, Medical Services | Tagged , , , , | Comments Off on Commercial Eyes at PharmAus19

Leukaemia Foundation – Raising Awareness of Blood Cancers

September is Blood Cancer Awareness month Through various parts of our business including market access and insights, regulatory services and medical communications, Commercial Eyes works with a number of organisations involved in improving and extending the lives of people living … Continue reading

Posted in Commercial Eyes, Life Sciences Industry | Tagged , , , , | Comments Off on Leukaemia Foundation – Raising Awareness of Blood Cancers

PHARMAC prepares to take over the procurement of medical devices

Access to medical devices in New Zealand is changing   The Therapeutic Products Bill will be published shortly, resulting in PHARMAC assuming responsibility for the procurement and funding of medical devices in addition to their current brief of medicines. This … Continue reading

Posted in Life Sciences Industry, Market Access, Medical Device | Tagged , , , , , , | Comments Off on PHARMAC prepares to take over the procurement of medical devices

PHARMAC issues a call for funding applications for medicines for rare disorders

Applications will be accepted until 5pm on the 5th of August 2019 and will be considered by the Rare Disorders Subcommittee at their meeting scheduled for the 24th of September 2019.   Eligibility criteria: The medicine must have been approved … Continue reading

Posted in Life Sciences Industry, Market Access | Tagged , , | Comments Off on PHARMAC issues a call for funding applications for medicines for rare disorders

Are you ready for the mandatory transition to eCTD for prescription medicines?

In October 2018 the TGA announced the long-awaited timelines for transition to eCTD. A staged implementation has been proposed for prescription medicines to reflect the current industry uptake of the eCTD format. The transition begins with new chemical entity, new … Continue reading

Posted in Life Sciences Industry, Regulatory Services, TGA | Tagged , , , | Comments Off on Are you ready for the mandatory transition to eCTD for prescription medicines?

November 2018 PBAC Meeting Agenda

The November 2018 PBAC Meeting is scheduled to conclude today. Here, the Commercial Eyes Market Access team provides an analysis of the meeting agenda, including Sponsors with multiple submissions and the nature of requested listings by type.     The … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , | Comments Off on November 2018 PBAC Meeting Agenda

PBAC Meeting Outcomes – July 2018

The July 2018 PBAC Meeting Outcomes were published on 17th August 2018. With 64 outcomes in total, the Commercial Eyes Market Access team provides an overview of PBAC decision making, including additional analysis conducted on biosimilar and oncology submissions.   … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC | Tagged , , | Comments Off on PBAC Meeting Outcomes – July 2018

Public Submissions to the August 2018 PBAC Special Meeting – Part 2

In the second part of this two-part series (Read Part 1 about here) we bring you further insight into opinions from the public submissions to the August 2018 PBAC Special Meeting. Opinions from the Public Submissions Outcomes of the PBAC’s … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , , | Comments Off on Public Submissions to the August 2018 PBAC Special Meeting – Part 2

Sponsors struggle with Ministerial discretion

The 2017 Medicines Australia Strategic Agreement with the Australian Government extended the existing five-year anniversary statutory price reduction (SPR) of 5% for F1 medicines and introduced new SPRs for drugs that have been listed for ten years and fifteen years … Continue reading

Posted in Life Sciences Industry, Market Access, PBS | Tagged , , , | Comments Off on Sponsors struggle with Ministerial discretion

The long road to PBS listing for Orkambi

Orkambi (lumacaftor and ivacaftor), a treatment for cystic fibrosis (CF), will go before the PBAC for a fourth time at the upcoming July 2018 PBAC meeting. So far, the road to reimbursement has been filled with multiple rejections, a strong … Continue reading

Posted in Life Sciences Industry, Market Access, PBAC, PBS | Tagged , , , | Comments Off on The long road to PBS listing for Orkambi
Copyright © 2014 Commercial Eyes